In addition, N-terminal pro-brain natriuretic peptide (NT-proBNP) has been verified to be involved in cancer progression and could play as a biomarker for monitoring anti-cancer drug-induced cardiotoxicity (95). This evidence concerns the gene NPPB and cancer.